JPWO2020033872A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020033872A5 JPWO2020033872A5 JP2021505954A JP2021505954A JPWO2020033872A5 JP WO2020033872 A5 JPWO2020033872 A5 JP WO2020033872A5 JP 2021505954 A JP2021505954 A JP 2021505954A JP 2021505954 A JP2021505954 A JP 2021505954A JP WO2020033872 A5 JPWO2020033872 A5 JP WO2020033872A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antigen
- antibody
- binding fragment
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862717435P | 2018-08-10 | 2018-08-10 | |
| US62/717,435 | 2018-08-10 | ||
| US201862764816P | 2018-08-15 | 2018-08-15 | |
| US62/764,816 | 2018-08-15 | ||
| PCT/US2019/045970 WO2020033872A1 (en) | 2018-08-10 | 2019-08-09 | A pharmaceutical composition for safe and effective treatment of knee and/or hip pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021533142A JP2021533142A (ja) | 2021-12-02 |
| JPWO2020033872A5 true JPWO2020033872A5 (enExample) | 2022-08-12 |
| JP7460598B2 JP7460598B2 (ja) | 2024-04-02 |
Family
ID=67811008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505954A Active JP7460598B2 (ja) | 2018-08-10 | 2019-08-09 | 膝および／または股関節痛の安全で効果的な処置用の医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11472870B2 (enExample) |
| EP (1) | EP3833687A1 (enExample) |
| JP (1) | JP7460598B2 (enExample) |
| KR (1) | KR20210043624A (enExample) |
| CN (1) | CN112839956A (enExample) |
| AU (1) | AU2019318556A1 (enExample) |
| CA (1) | CA3108697A1 (enExample) |
| IL (1) | IL280550B2 (enExample) |
| MX (1) | MX2021001549A (enExample) |
| WO (1) | WO2020033872A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7532290B2 (ja) * | 2021-03-09 | 2024-08-13 | エヌ・ティ・ティ・コミュニケーションズ株式会社 | 患者追跡調査支援システム、患者追跡調査支援方法、支援制御装置、端末装置およびプログラム |
| EP4433500A1 (en) | 2021-11-19 | 2024-09-25 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for reducing centralized pain |
| US20240002491A1 (en) * | 2022-04-27 | 2024-01-04 | Regeneron Pharmaceuticals, Inc. | Methods for selecting patients for treatment with an ngf antagonist |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| CN102746399B (zh) | 2002-12-24 | 2016-03-02 | 里纳特神经系统学公司 | 抗ngf抗体及其使用方法 |
| US7569364B2 (en) * | 2002-12-24 | 2009-08-04 | Pfizer Inc. | Anti-NGF antibodies and methods using same |
| ME00226B (me) | 2004-07-15 | 2011-02-10 | Medarex Llc | Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade |
| RS52176B (sr) | 2006-06-02 | 2012-08-31 | Regeneron Pharmaceuticals Inc. | Antitela visokog afiniteta prema humanom il-6 receptoru |
| KR101709488B1 (ko) * | 2007-08-10 | 2017-02-24 | 리제너론 파아마슈티컬스, 인크. | 인간 신경성장인자에 대한 고친화성 인간 항체 |
| US8309088B2 (en) * | 2007-08-10 | 2012-11-13 | Regeneron Pharmaceuticals, Inc. | Method of treating osteoarthritis with an antibody to NGF |
| US20110256135A1 (en) * | 2010-03-17 | 2011-10-20 | Wolfgang Fraunhofer | Anti-nerve growth factor (ngf) antibody compositions |
| JOP20190250A1 (ar) | 2010-07-14 | 2017-06-16 | Regeneron Pharma | صيغ مستقرة تحتوي على الأجسام المضادة لمضاد عامل نمو الأعصاب |
| PL2624865T3 (pl) | 2010-10-06 | 2018-11-30 | Regeneron Pharmaceuticals, Inc. | Stabilizowane preparaty zawierające przeciwciała przeciwko receptorowi interleukiny-4 (IL-4R) |
| US9617334B2 (en) * | 2012-06-06 | 2017-04-11 | Zoetis Services Llc | Caninized anti-NGF antibodies and methods thereof |
| AU2017366870B2 (en) | 2016-11-29 | 2024-09-19 | Regeneron Pharmaceuticals, Inc. | A pharmaceutical composition for averting opioid addiction |
-
2019
- 2019-08-09 EP EP19762255.8A patent/EP3833687A1/en active Pending
- 2019-08-09 WO PCT/US2019/045970 patent/WO2020033872A1/en not_active Ceased
- 2019-08-09 IL IL280550A patent/IL280550B2/en unknown
- 2019-08-09 JP JP2021505954A patent/JP7460598B2/ja active Active
- 2019-08-09 AU AU2019318556A patent/AU2019318556A1/en active Pending
- 2019-08-09 KR KR1020217007170A patent/KR20210043624A/ko not_active Ceased
- 2019-08-09 MX MX2021001549A patent/MX2021001549A/es unknown
- 2019-08-09 US US16/536,706 patent/US11472870B2/en active Active
- 2019-08-09 CA CA3108697A patent/CA3108697A1/en active Pending
- 2019-08-09 CN CN201980066402.2A patent/CN112839956A/zh active Pending
-
2021
- 2021-10-26 US US17/510,798 patent/US20220041708A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013155906A (ru) | Антитела анти-angptl3 и их применение | |
| RU2016136364A (ru) | Способы лечения или предупреждения астмы посредством введения антагониста il-4r | |
| AU2011268229B2 (en) | Arthritis treatment | |
| JP2019523295A5 (enExample) | ||
| RU2019134352A (ru) | Новые биспецифические антигенсвязывающие молекулы, обладающие способностью специфически связываться с cd40 и fap | |
| JP2013542194A5 (enExample) | ||
| RU2010108525A (ru) | Антитела человека с высокой аффинностью к фактору роста нервов человека | |
| RU2018131237A (ru) | Способы лечения атопического дерматита с помощью антагониста il-4r | |
| RU2016130056A (ru) | Способы лечения кожной инфекции путем введения антагониста il-4r | |
| JP2018512435A5 (enExample) | ||
| JP2019512472A5 (enExample) | ||
| RU2016122340A (ru) | Il-17a-связующий агент и способы его применения | |
| JP2025072440A5 (enExample) | ||
| JP6663910B2 (ja) | 抗ＴＮＦ−α抗体療法を受けた乾癬患者を治療するための方法 | |
| FI3880186T3 (fi) | PD-1-inhibiittoreiden intralesionaalinen antaminen ihosyövän hoitamiseksi | |
| JPWO2020033872A5 (enExample) | ||
| JP2019535716A5 (enExample) | ||
| JPWO2021224499A5 (enExample) | ||
| JPWO2022053654A5 (enExample) | ||
| JPWO2022053655A5 (enExample) | ||
| JPWO2022053653A5 (enExample) | ||
| RU2217166C2 (ru) | Гуманизированные антитела, которые распознают веротоксин ii, и продуцирующая их линия клеток | |
| RU2021105797A (ru) | Фармацевтическая композиция для безопасного и эффективного лечения боли колена и/или тазобедренного сустава | |
| JPWO2023086817A5 (enExample) | ||
| RU2000132226A (ru) | Гуманизированные антитела, которые распознают веротоксин ii, и продуцирующая их линия клеток |